MarginsXMarginsX
Home › Markets › Health Care › MOH

Molina Healthcare Inc (MOH)

MOH trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$233.09
+11.27% on the day
Market cap
$12.2B
Large cap
Revenue · 2025
$45.4B
+11.7% on 2024
Net income · 2025
$472.0M
1.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1179929/000117992926000005/0001179929-26-000005-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMOH on NYSE
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2003
SEC CIK0001179929
SEC industry codeHospital & Medical Service Plans
Incorporated inDE

Financials · 2025

LineValue
Revenue$45.4B
Net income$472.0M
Operating income$781.0M
Net margin1.0%
Operating margin1.7%
Revenue growth+11.7%
Cash$4.2B
Total assets$15.6B
P/E (computed)25.8×
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$4.5B cash at September 30, 2026
Share count, 1 year
+1.6%
2025-10-17 to 2026-10-16 · -10.5% over 3 years
Going-concern doubt
No
10-Q filed October 22, 2026
Insider net buying, 12 months
-$3.5M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-22
Cash and burn$4.5B cash; operating cash flow $82.8M a quarter.Report 2026-09-30
Shares outstanding52,200,000 (2026-10-16); 51,400,000 a year earlier; 58,300,000 three years earlier.Cover page 2026-10-16
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Los Angeles, California, United StatesPCAOB Form AP 2026-03-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $100K, sold $3.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$11.1B$38.0M-$159.0M$4.5B$3.8B$44.1B10-Q 2026-10-22
Q2 2026
2026-06-30
$10.9B$60.0M-$294.0M$5.0B$3.8B$44.5B10-Q 2026-07-23
Q1 2026
2026-03-31
$10.8B$14.0M$1.1B$5.3B$3.8B$45.1B10-Q 2026-04-23
Q4 2025
2025-12-31
$11.4B-$160.0M-$298.0M$4.2B$3.8B$45.4B10-K 2026-02-10
Q3 2025
2025-09-30
$11.5B$79.0M-$125.0M$4.2B$3.7B$44.5B10-Q 2026-10-22
Q2 2025
2025-06-30
$11.4B$255.0M-$302.0M$4.5B$3.4B$43.4B10-Q 2026-07-23
Q1 2025
2025-03-31
$11.1B$298.0M$190.0M$4.9B$3.6B$41.9B10-Q 2026-04-23
Q4 2024
2024-12-31
$10.5B$251.0M-$224.0M$4.7B$2.9B$40.6B10-K 2026-02-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52018-03-06
Latest annual report10-K2026-02-10
Latest quarterly / interim10-Q2026-10-22
Latest current report
FORM 8-K
8-K2026-11-06
Latest proxyDEFA14A2026-03-23

Source: SEC EDGAR submissions feed, 1,009 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.2%
1 month-0.0%
3 months+1.8%
Year to date+20.7%
1 year+51.3%
From 52-week high-13.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
OSCROscar Health Inc.$31.33+0.90%$9.7B
HSICHenry Schein Inc.$84.96-1.46%$9.4B
GHGuardant Health Inc.$144.03-5.06%$19.5B
RDNTRadNet Inc.$76.89+0.61%$6.1B
CAICaris Life Sciences Inc.$21.00-8.85%$6.0B
CONConcentra Group Holdings Parent Inc.$43.44+2.09%$5.5B
DGXQuest Diagnostics Incorporated$262.21+1.01%$28.8B
ILMNIllumina Inc.$198.00-4.35%$29.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier